Nhận Dạng Quốc Tế & Đặc Tính Hóa Học
Monoisotopic mass
231.123484132
InChI
InChI=1S/C12H16F3N/c1-3-16-9(2)7-10-5-4-6-11(8-10)12(13,14)15/h4-6,8-9,16H,3,7H2,1-2H3
InChI Key
InChIKey=DBGIVFWFUFKIQN-UHFFFAOYSA-N
IUPAC Name
ethyl({1-[3-(trifluoromethyl)phenyl]propan-2-yl})amine
Traditional IUPAC Name
fenfluramine
SMILES
CCNC(C)CC1=CC(=CC=C1)C(F)(F)F
Độ tan chảy
108-112 °C at 1.20E+01 mm Hg
pKa (Strongest Basic)
10.22
Refractivity
59.2 m3·mol-1
Dược Lực Học :
Used to treat obesity, Fenfluramine decreases caloric intake by increasing serotonin levels in the brain's synapses. Fenfluramine acts as a serotonin reuptake inhibitor. It also causes release of serotonin from the synaptosomes. This in turn increases serotonin transmission in the feeding centre of the brain which suppresses appetite.
Cơ Chế Tác Dụng :
Fenfluramine was withdrawn from the U.S. market in 1997 after reports of heart valve disease and pulmonary hypertension, including a condition known as cardiac fibrosis.
Fenfluramine binds to the serotonin reuptake pump. This causes inhbition of serotonin uptake and release of serotonin. The increased levels of serotonin lead to greater serotonin receptor activation which in turn lead to enhancement of serotoninergic transmission in the centres of feeding behavior located in the hypothalamus. This suppresses the appetite for carbohydrates.
Dược Động Học :
▧ Absorption :
Fenfluramine is well-absorbed from the gastrointestinal tract, and a maximal anorectic effect is generally seen after 2 to 4 hours.
▧ Metabolism :
Hepatic.
▧ Half Life :
20 hours
Độc Tính :
Agitation and drowsiness, confusion, flushing, tremor (or shivering), fever, sweating, abdominal pain, hyperventilation, and dilated non-reactive pupils seem frequent in fenfluramine overdosage. Reflexes may be either exaggerated or depressed and some patients may have rotary nystagmus. Tachycardia may be present, but blood pressure may be normal or only slightly elevated. Convulsions, coma, and ventricular extrasystoles, culminating in ventricular fibrillation, and cardiac arrest, may occur at higher dosages. Less than 5 mg/kg are toxic to humans. Five-ten mg/kg may produce coma and convulsions. Reported single overdoses have ranged from 300 to 2000 mg; the lowest reported fatal dose was a few hundred mg in a small child, and the highest reported nonfatal dose was 1800 mg in an adult. Most deaths were apparently due to respiratory failure and cardiac arrest. Toxic effects will appear within 30 to 60 minutes and may progress rapidly to potentially fatal complications in 90 to 240 minutes. Symptoms may persist for extended periods depending upon the dose ingested.
Chỉ Định :
For the management of exogenous obesity as a short-term (a few weeks) adjunct in a regimen of weight reduction based on caloric restriction.
Tương Tác Thuốc :
-
Acetophenazine
Decreased anorexic effect, may increase psychotic symptoms
-
Alimemazine
Decreased anorexic effect, may increase psychotic symptoms
-
Chlorpromazine
Decreased anorexic effect, may increase psychotic symptoms
-
Ethopropazine
Decreased anorexic effect, may increase psychotic symptoms
-
Fluoxetine
Risk of serotoninergic syndrome
-
Fluphenazine
Decreased anorexic effect, may increase psychotic symptoms
-
Fluvoxamine
Risk of serotoninergic syndrome
-
Guanethidine
Fenfluramine may decrease the effect of guanethidine.
-
Insulin Aspart
Fenfluramine increases the effect of insulin
-
Insulin Detemir
Fenfluramine increases the effect of insulin
-
Insulin Glulisine
Fenfluramine increases the effect of insulin
-
Isocarboxazid
Possible hypertensive crisis
-
Mesoridazine
Decreased anorexic effect, may increase psychotic symptoms
-
Methdilazine
Decreased anorexic effect, may increase psychotic symptoms
-
Methotrimeprazine
Decreased anorexic effect, may increase psychotic symptoms
-
Paroxetine
Risk of serotoninergic syndrome
-
Perphenazine
Decreased anorexic effect, may increase psychotic symptoms
-
Phenelzine
Possible hypertensive crisis
-
Prochlorperazine
Decreased anorexic effect, may increase psychotic symptoms.
-
Promazine
Decreased anorexic effect, may increase psychotic symptoms
-
Promethazine
Decreased anorexic effect, may increase psychotic symptoms.
-
Propericiazine
Decreased anorexic effect, may increase psychotic symptoms.
-
Propiomazine
Decreased anorexic effect, may increase psychotic symptoms
-
Rasagiline
Possible hypertensive crisis
-
Thiethylperazine
Decreased anorexic effect, may increase psychotic symptoms
-
Thioridazine
Decreased anorexic effect, may increase psychotic symptoms
-
Tranylcypromine
Possible hypertensive crisis
-
Trifluoperazine
Decreased anorexic effect, may increase psychotic symptoms
-
Triflupromazine
Decreased anorexic effect, may increase psychotic symptoms
-
Venlafaxine
Risk of serotoninergic syndrome
Liều Lượng & Cách Dùng :
Tablet - Oral
Dữ Kiện Thương Mại
Nhà Sản Xuất
-
Sản phẩm biệt dược : Adifax
-
Sản phẩm biệt dược : Ponderax
-
Sản phẩm biệt dược : Pondimin